Paukovitsch Michael, Felbel Dominik, Jandek Madeleine, Keßler Mirjam, Rottbauer Wolfgang, Markovic Sinisa, Groeger Matthias, Tadic Marijana, Schneider Leonhard Moritz
Department of Cardiology, University Heart Center Ulm, Ulm, Germany.
Front Cardiovasc Med. 2023 Jun 23;10:1143702. doi: 10.3389/fcvm.2023.1143702. eCollection 2023.
Mitral annular alterations in the context of heart failure often lead to severe functional mitral regurgitation (FMR), which should be treated with transcatheter edge-to-edge repair (M-TEER) according to current guidelines. M-TEER's effects on mitral valve (MV) annular remodeling have not been well elucidated.
141 consecutive patients undergoing M-TEER for treatment of FMR were included in this investigation. Comprehensive intraprocedural transesophageal echocardiography was used to assess the acute effects of M-TEER on annular geometry.
Average patient age was 76.2 ± 9.6 years and 46.1% were female patients. LV ejection fraction was reduced (37.0% ± 13.7%) and all patients had mitral regurgitation (MR) grade ≥III. M-TEER achieved optimal MR reduction (MR ≤ I) in 78.6% of patients. Mitral annular anterior-posterior diameters (A-Pd) were reduced by -6.2% ± 9.5% on average, whereas anterolateral-posteromedial diameters increased (3.7% ± 8.9%). Overall, a reduction in MV annular areas was observed (2D: -1.8% ± 13.1%; 3D: -2.7% ± 13.7%), which strongly correlated with A-Pd reduction (2D: = 0.6, < 0.01; 3D: = 0.65, < 0.01). Patients that achieved A-Pd reduction above the median (≥6.3%) showed significantly lower rates of the composite endpoint rehospitalization for heart failure or all-cause mortality than those with less A-Pd reduction (9.9% vs. 28.6%, = 0.037, log-rank = 0.039). Furthermore, patients reaching the composite endpoint had an increase in annular area (2D: 3.0% ± 15.4%; 3D: 1.9% ± 15.3%), whereas those not reaching the endpoint showed a decrease (2D: -2.7% ± 12.4%; 3D: -3.6% ± 13.3%), although residual MR after M-TEER was similar between these groups ( = 0.57). In multivariate Cox regression adjusted for baseline MR, A-Pd reduction ≥6.3% remained a significant predictor of the combined endpoint (OR: 0.35, 95% CI: 0.14-0.85, = 0.02).
Our findings indicate that effects of M-TEER in FMR are not limited to MR reduction, but also have significant impact on annular geometry. Moreover, A-Pd reduction, which mediates annular remodeling, has a significant impact on clinical outcome independent of residual MR.
心力衰竭情况下二尖瓣环改变常导致严重功能性二尖瓣反流(FMR),根据现行指南,应采用经导管缘对缘修复术(M-TEER)进行治疗。M-TEER对二尖瓣(MV)环重塑的影响尚未得到充分阐明。
本研究纳入了141例连续接受M-TEER治疗FMR的患者。术中采用综合经食管超声心动图评估M-TEER对瓣环几何形状的急性影响。
患者平均年龄为76.2±9.6岁,女性患者占46.1%。左心室射血分数降低(37.0%±13.7%),所有患者二尖瓣反流(MR)均≥III级。M-TEER使78.6%的患者实现了最佳MR降低(MR≤I级)。二尖瓣环前后径(A-Pd)平均缩小了-6.2%±9.5%,而前外侧-后内侧径增加(3.7%±8.9%)。总体而言,观察到MV环面积减小(二维:-1.8%±13.1%;三维:-2.7%±13.7%),这与A-Pd缩小密切相关(二维:r = 0.6,P<0.01;三维:r = 0.65,P<0.01)。A-Pd缩小超过中位数(≥6.3%)的患者,其因心力衰竭再住院或全因死亡的复合终点发生率显著低于A-Pd缩小较少的患者(9.9%对28.6%,P = 0.037,对数秩检验P = 0.039)。此外,达到复合终点的患者环面积增加(二维:3.0%±15.4%;三维:1.9%±15.3%),而未达到终点的患者环面积减小(二维:-2.7%±12.4%;三维:-3.6%±13.3%),尽管这些组之间M-TEER后的残余MR相似(P = 0.57)。在对基线MR进行校正的多变量Cox回归分析中,A-Pd缩小≥6.3%仍然是复合终点的显著预测因素(OR:0.35,95%CI:0.14-0.85,P = 0.02)。
我们的研究结果表明,M-TEER治疗FMR的作用不仅限于降低MR,还对瓣环几何形状有显著影响。此外,介导瓣环重塑的A-Pd缩小对临床结局有显著影响,且独立于残余MR。